Exicure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exicure and other ETFs, options, and stocks.About XCUR
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN.
CEOAndy Yoo
CEOAndy Yoo
Employees7
Employees7
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2011
Founded2011
Employees7
Employees7
XCUR Key Statistics
Market cap39.13M
Market cap39.13M
Price-Earnings ratio-3.94
Price-Earnings ratio-3.94
Dividend yield—
Dividend yield—
Average volume44.44K
Average volume44.44K
High today$6.20
High today$6.20
Low today$5.96
Low today$5.96
Open price$6.10
Open price$6.10
Volume50.31K
Volume50.31K
52 Week high$15.91
52 Week high$15.91
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
The current Exicure(XCUR) stock price is $6.00, with a market capitalization of 39.13M. The stock trades at a price-to-earnings (P/E) ratio of -3.94.
During the trading session on 2026-01-14, Exicure(XCUR) shares reached a daily high of $6.20 and a low of $5.96. At a current price of $6.00, the stock is +0.7% higher than the low and still -3.2% under the high.
Trading volume for Exicure(XCUR) stock has reached 50.31K, versus its average volume of 44.44K.
The stock's 52-week range extends from a low of $3.10 to a high of $15.91.
The stock's 52-week range extends from a low of $3.10 to a high of $15.91.
People also own
Based on the portfolios of people who own XCUR. This list is generated using Robinhood data, and it’s not a recommendation.